- Home
- TLSI vs RILY Comparison
TLSI vs RILY Comparison
Compare TLSI & RILY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- RILY
- Stock Information
- Founded
- TLSI 2010
- RILY 1973
- Country
- TLSI United States
- RILY United States
- Employees
- TLSI N/A
- RILY N/A
- Industry
- TLSI Medical Specialities
- RILY Investment Managers
- Sector
- TLSI Health Care
- RILY Finance
- Exchange
- TLSI Nasdaq
- RILY Nasdaq
- Market Cap
- TLSI 160.4M
- RILY 142.1M
- IPO Year
- TLSI N/A
- RILY 2007
- Fundamental
- Price
- TLSI $5.62
- RILY $4.00
- Analyst Decision
- TLSI Strong Buy
- RILY
- Analyst Count
- TLSI 6
- RILY 0
- Target Price
- TLSI $11.75
- RILY N/A
- AVG Volume (30 Days)
- TLSI 66.8K
- RILY 1.1M
- Earning Date
- TLSI 03-27-2025
- RILY 03-31-2025
- Dividend Yield
- TLSI N/A
- RILY 12.50%
- EPS Growth
- TLSI N/A
- RILY N/A
- EPS
- TLSI N/A
- RILY N/A
- Revenue
- TLSI $29,431,000.00
- RILY $854,383,000.00
- Revenue This Year
- TLSI $55.43
- RILY N/A
- Revenue Next Year
- TLSI $50.09
- RILY N/A
- P/E Ratio
- TLSI N/A
- RILY N/A
- Revenue Growth
- TLSI 58.99
- RILY N/A
- 52 Week Low
- TLSI $3.50
- RILY $2.73
- 52 Week High
- TLSI $10.42
- RILY $40.09
- Technical
- Relative Strength Index (RSI)
- TLSI 55.78
- RILY 42.32
- Support Level
- TLSI $5.06
- RILY $4.15
- Resistance Level
- TLSI $5.72
- RILY $4.61
- Average True Range (ATR)
- TLSI 0.37
- RILY 0.28
- MACD
- TLSI 0.03
- RILY -0.05
- Stochastic Oscillator
- TLSI 90.65
- RILY 18.12
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About RILY B. Riley Financial Inc.
B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.